Biomarkers /

OLFM4

Back to Biomarkers List

Overview

Location [1]
13q14.3
Protein [2]
Olfactomedin-4
Synonyms [1]
GC1, OlfD, hGC-1, GW112, UNQ362, hOLfD, OLM4, bA209J19.1

OLFM4 is altered in 0.10% of all cancers with lung adenocarcinoma, breast invasive ductal carcinoma, thyroid gland papillary carcinoma, adenocarcinoma of unknown primary, and bladder urothelial carcinoma having the greatest prevalence of alterations [3].

OLFM4 GENIE Cases - Top Diseases

The most common alteration in OLFM4 is OLFM4-RET Fusion (0.10%) [3].

OLFM4 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.